telehealth.helpFind my match

Home Weight loss (GLP-1) By state California

Medi-Cal's 2026 GLP-1 Cutoff: 8 programs ship to CA

California is one of four states whose Medicaid program dropped GLP-1 coverage for obesity in KFF's January 2026 review. On January 1, 2026, Medi-Cal stopped paying for weight-loss GLP-1s for adults 21 and older, and the state's HMO rules only guarantee weight coverage at a BMI of 40 or more. If you lost coverage, or never had it, here is what is left and where Californians turn now. The lowest price we found from a program that ships to California: compounded semaglutide at $89 a month on a 12-month plan ($99 month to month) at Lttl.

  • Updated
  • Prices read Nov 12, 2026

California at a glance

California Medicaid
Does not cover for weight loss
State employee plan
Not published
Adults with obesity
29.1% (2024)
Programs we compare that ship to CA
8 of 22

Online GLP-1 programs for California, cheapest first

Programs that ship to California. Prescribed online by a licensed clinician; medication and delivery included.

How we pick and check programs

Our pick for November 2026

Daily oral plan
Intro offer: from $7 a day

A daily oral GLP-1 plan. No needles, no injections

GLP-1 protocol from$199/moon the 3-month plan with the $100 welcome credit ($299 without), shipped monthly; the home page names no form for this plan (the oral offer is from $7 a day)
Visit HumeCare Read our HumeCare review

Compounded semaglutide in California: lowest monthly price

#ProgramLowest priceMonth to monthLink
1LttlCheapest$89/mo 12-month plan$99 / 4 wksVisitLttl
2BetterMe Rx$99/mo 12-month plan$199/moVisitBetterMe Rx
3Refills$99/mo $99 / 4 wksVisitRefills
4Direct Meds$297/mo $297/moVisitDirect Meds
5GalaFrom $69/mo starting price, plan length not statedNot statedVisitGala
6TrimRxFrom $349/mo starting price, plan length not statedNot statedVisitTrimRx

Compounded tirzepatide in California: lowest monthly price

#ProgramLowest priceMonth to monthLink
1MaximusCheapest$99.99/mo 12-month planNot offeredVisitMaximus
2Lttl$139/mo 12-month plan$149 / 4 wksVisitLttl
3BetterMe Rx$159/mo 12-month plan$249/moVisitBetterMe Rx
4Refills$159/mo $159 / 4 wksVisitRefills
5Direct Meds$399/mo $399/moVisitDirect Meds
6GalaFrom $99/mo starting price, plan length not statedNot statedVisitGala
7TrimRxFrom $279/mo starting price, plan length not statedNot statedVisitTrimRx
  1. Low month-to-month#1
    Up to $140 off your first month

    Compounded semaglutide for $99, month to month

    Semaglutide$99/momonth to month (4-week supply); $89 on a 12-month plan
    Visit Lttl Read our Lttl review
  2. Pills or shots#2
    Semaglutide from $99/mo

    Choose weekly shots or daily tablets; shots from $99/mo on the 12-month plan

    Semaglutide shots from$99/moon the 12-month plan; $199 month to month
    Visit BetterMe Rx Read our BetterMe Rx review
  3. No contract#3
    Fall sale: 40% off

    Compounded semaglutide as low as $99 a month

    Semaglutide as low as$99/moper 4-week supply, month to month; shown during a 40% fall sale
    4.2 on Trustpilot1,779 reviews ·
    Visit Refills Read our Refills review
  4. Low-cost tirzepatide#4
    Same price at every dose

    Compounded tirzepatide from $99.99 a month

    Tirzepatide from$99.99/moon the 12-month plan, paid up front; $199.99 on 2 months
    4.4 on Trustpilot1,106 reviews ·
    Visit Maximus Read our Maximus review
  5. Delivery in 1-2 days#5
    Fall sale: $150 off

    Same price at every dose, at your door in 1-2 days

    Semaglutide$297/momonth to month: medication, doctor visits and shipping included; tirzepatide $399; fall sale: "starting at $147", "$150 off"
    4.5 on Trustpilot17,724 reviews ·
    Visit Direct Meds Read our Direct Meds review

3 more programs are in the price tables above.

After the Medi-Cal cutoff: what changed on January 1, 2026

The 2025-26 state budget ended Medi-Cal coverage of GLP-1s prescribed for weight loss for members 21 and older. Zepbound and Saxenda came off the Medi-Cal Contract Drugs List, Wegovy is no longer covered for weight loss, and prior approvals for weight loss expired. DHCS gave about 90 days' notice, but there was no grandfathering: requests to continue therapy are denied. For members who were mid-treatment, the change meant either stopping or finding a new way to pay. Diabetes coverage did not change.

A few doors stayed open. Since April 1, 2026, Wegovy prescribed for the liver condition MASH no longer needs prior authorization, as long as the claim carries the right diagnosis code. Wegovy for heart disease and Zepbound for obstructive sleep apnea can still be requested through prior authorization. Ozempic, Mounjaro and the other diabetes GLP-1s remain covered for type 2 diabetes, and members under 21 can still be reviewed for medical necessity.

For everyone else, self-pay became the main path. Online programs ship across California, from San Diego to Redding, and compounded options often cost far less per month than brand-name list prices. Compare total monthly cost, not just the first-month price, before you switch. A program that offers both compounded and brand-name medication makes it easier to switch later if your coverage returns. Ask what follow-up visits cost, too.

  • Medi-Cal ended coverage of GLP-1s for weight loss on January 1, 2026. (medi-calrx.dhcs.ca.gov)
  • Since April 1, 2026, Medi-Cal Rx covers Wegovy for MASH without prior authorization when the claim carries the MASH diagnosis code; Zepbound for obstructive sleep apnea and Wegovy for cardiovascular disease still go through prior authorization. (medi-calrx.dhcs.ca.gov)
  • Medi-Cal Rx removed Zepbound and Saxenda from its Contract Drugs List on January 1, 2026; Ozempic, Rybelsus, Mounjaro, Victoza, Byetta, Bydureon and Trulicity stay listed with a type 2 diabetes restriction, and members under 21 can be reviewed under EPSDT. (medi-calrx.dhcs.ca.gov)
  • California law requires Knox-Keene regulated health plans to cover GLP-1 drugs for diabetes and for morbid obesity (BMI of 40 or higher), and CalPERS' Blue Shield and Kaiser Permanente HMO plans cover them for morbid obesity with prior authorization. (calpers.ca.gov)
  • CalPERS staff estimated that SB 1089's coverage mandate, as amended May 14, 2026, would raise CalPERS premiums by about $437.3 million, or $28.09 per member per month, in its first year. (calpers.ca.gov)
  • SB 1089 was chaptered as Chapter 725, Statutes of 2026; subject to funding, it lets the state partner to lower prices for at least one FDA-approved GLP-1 obesity drug under CalRx. (leginfo.legislature.ca.gov)
  • The CDC's 2025 adult obesity table lists California with insufficient data for a state estimate. (cdc.gov)

The BMI 40 line in California HMO plans

California's Knox-Keene Act, the law that governs HMO-style health plans, requires those plans to cover GLP-1 drugs for diabetes and for morbid obesity, which means a BMI of 40 or higher. Below that line, weight-loss coverage depends on the plan and on what the employer chose to buy. CalPERS, the state's public employee health program, says its Blue Shield of California and Kaiser Permanente HMO plans cover GLP-1s for morbid obesity with prior authorization. Its self-insured pharmacy benefit covers only older weight-loss drugs that are not GLP-1s.

That leaves a lot of people in the middle. CalPERS estimates that about 360,000 of its members, 28% of its Basic and Medicare population, have a BMI of 30 or more, and another 240,000 are overweight. Most of them would not clear a BMI 40 bar. If you are a Kaiser or Blue Shield member with a BMI between 30 and 40 and no diabetes, ask whether your employer added a weight-loss drug benefit before you assume the answer is no.

SB 1089: a coverage mandate that became a CalRx price plan

In 2026 the Legislature took up SB 1089. As amended in spring 2026, it would have required CalPERS health plans to cover at least one GLP-1 for overweight and obesity from 2028, structured as a five-year pilot. CalPERS staff asked the board to oppose it in June 2026, estimating a first-year premium increase of about $437.3 million, or $28.09 per member per month, spread across every member and employer.

The version that became law, Chapter 725 of the Statutes of 2026, dropped the mandate. If the Legislature funds it, the California Health and Human Services Agency may partner with others to lower prices and ease shortages for at least one FDA-approved GLP-1 obesity drug under the state's CalRx program, aiming for prices at or below what Medi-Cal paid in 2025. It creates no benefit you can use today.

How Medi-Cal Rx now sorts a GLP-1 claim

Medi-Cal Rx splits the class in two. Ozempic, Rybelsus, Mounjaro, Victoza, Byetta, Bydureon and Trulicity stay on the Contract Drugs List with a type 2 diabetes diagnosis restriction, and a claim without that diagnosis is rejected. Zepbound and Saxenda were taken off the list entirely, so pharmacy claims for them are denied unless a prior authorization is approved for a use other than weight loss, such as sleep apnea for Zepbound. Every prior approval for these drugs expired on December 31, 2025.

One more gap: the CDC's 2025 state obesity table lists California as having insufficient data, so there is no fresh statewide rate this year. For an adult on Medi-Cal who wants a GLP-1 for weight alone, the public route is closed, and a cash program that ships to California is the realistic option.

GLP-1 in California: questions

Does Medi-Cal still cover Wegovy or Zepbound?

Not for weight loss. Since January 1, 2026, Medi-Cal does not pay for GLP-1s prescribed for weight loss for members 21 and older. Wegovy is still covered for MASH, without prior authorization since April 2026, and can be approved for heart disease. Zepbound can be approved for sleep apnea. If you only need help with weight, compare the self-pay programs on this page.

I lost my Medi-Cal GLP-1 coverage. Can I keep going without a gap?

Possibly. A clinician at an online program reviews your history and decides whether to prescribe and at what dose. Bring your prescription history. Our comparison shows which programs serve California and their monthly prices.

Does Kaiser cover Wegovy in California if my BMI is under 40?

Often not. California's HMO rules only require GLP-1 coverage for diabetes and for a BMI of 40 or higher, and below that it depends on your plan. CalPERS, for example, says its Kaiser and Blue Shield HMOs cover GLP-1s for morbid obesity with prior authorization. Ask Kaiser member services or your HR team whether your employer added a weight-loss drug benefit. If not, compare cash programs here.

Can a California resident order semaglutide online legally?

Yes. Telehealth prescribing is allowed in California when a clinician licensed in the state reviews your case. The programs we list say on their own sites that they serve California. You will fill out a health form, and some programs ask for a photo ID or lab results. Compare them below.

What is the cheapest GLP-1 option in California right now?

Compounded semaglutide programs have the lowest monthly prices in our list. If you want a brand-name drug, Maximus ships to California and sells Wegovy, the Wegovy pill and Zepbound. Our table lists current prices for programs that ship to California, from Los Angeles to the far north.

Does CalPERS cover Wegovy or Zepbound for weight loss?

Only in limited cases. CalPERS says its Blue Shield and Kaiser Permanente HMO plans cover GLP-1s for morbid obesity, a BMI of 40 or higher, with prior authorization. Its self-insured pharmacy benefit covers only older non-GLP-1 weight-loss drugs. A 2026 bill that would have required broader CalPERS coverage was changed before it passed.

What did SB 1089 change for GLP-1 prices in California?

Nothing yet at the pharmacy counter. The final law, Chapter 725 of 2026, lets the state's health agency seek a partnership to lower prices for at least one GLP-1 obesity drug under CalRx, if the Legislature funds it. The goal is prices at or below what Medi-Cal paid in 2025. Until a deal exists, cash programs are the way to keep costs down.

See programs for California All states

Sources: medi-calrx.dhcs.ca.gov · cdc.gov